Heart Vessels. 2021 Aug 04; doi: 10.1007/s00380-021-01919-7. Epub 2021 Aug 04.

Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1).

Heart and vessels

Akihiro Takasaki, Tairo Kurita, Yosuke Hirabayashi, Hiroshi Matsuo, Akiko Tanoue, Jun Masuda, Takashi Yamanaka, Kan Katayama, Hirofumi Machida, Takehiko Ichikawa, Masaaki Ito, Kaoru Dohi

PMID: 34347137 DOI: 10.1007/s00380-021-01919-7

Abstract

Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 (p < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128.

© 2021. Springer Japan KK, part of Springer Nature.

Keywords: AMI; Hemodialysis; Killip class; Prognosis

References

1. Nitta K, Abe M, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Goto S, Wakasugi M, Yamamoto K, Nakamoto H, Maeno K, Kawata T, Oyama C, Seino K, Sato T, Sato S, Ito M, Kazama J, Ueda A, Saito O, Ando T, Ogawa T, Kumagai H, Terawaki H, Ando R, Abe M, Kashiwagi T, Hamada C, Shibagaki Y, Hirawa N, Shimada H, Ishida Y, Yokoyama H, Miyazaki R, Fukasawa M, Kamijyo Y, Matsuoka T, Kato A, Mori N, Ito Y, Kasuga H, Koyabu S, Arimura T, Hashimoto T, Inaba M, Hayashi T, Yamakawa T, Nishi S, Fujimori A, Yoneda T, Negi S, Nakaoka A, Ito T, Sugiyama H, Masaki T, Nitta Y, Okada K, Yamanaka M, Kan M, Ota K, Tamura M, Mitsuiki K, Ikeda Y, Nishikido M, Miyata A, Tomo T, Fujimoto S, Nosaki T, Oshiro Y (2020) Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes. Ren Replace Ther 6:1–16 - PubMed
2. Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I (2013) Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan. Ther Apher Dial 17:298–304 - PubMed
3. Shroff GR, Li S, Herzog CA (2015) Trends in mortality following acute myocardial infarction among dialysis patients in the united states over 15 years. J Am Heart Assoc 4(10):e002460 - PubMed
4. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362:2155–2165 - PubMed
5. Movahed M-R, John J, Hashemzadeh M, Jamal MM, Hashemzadeh M (2009) Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988–2004) based on race, gender, infarct location and comorbidities. Am J Cardiol 104:1030–1034 - PubMed
6. Szummer K, Lindhagen L, Evans M, Spaak J, Koul S, Åkerblom A, Carrero JJ, Jernberg T (2019) Treatments and mortality trends in cases with and without dialysis who have an acute myocardial infarction: an 18-year nationwide experience. Circ Cardiovasc Qual Outcomes 12(9):e005879 - PubMed
7. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362:2155–2165 - PubMed
8. Fukuoka S, Kurita T, Dohi K, Masuda J, Seko T, Tanigawa T, Saito Y, Kakimoto H, Makino K, Ito M (2019) Untangling the obesity paradox in patients with acute myocardial infarction after primary percutaneous coronary intervention (detail analysis by age). Int J Cardiol 289:12–18 - PubMed
9. Masuda J, Kishi M, Kumagai N, Yamazaki T, Sakata K, Higuma T, Ogimoto A, Dohi K, Tanigawa T, Hanada H, Nakamura M, Sokejima S, Takayama M, Higaki J, Yamagishi M, Okumura K, Ito M (2018) Rural-urban disparity in emergency care for acute myocardial infarction in Japan. Circ J 82:1666–1674 - PubMed
10. Takasaki A, Kurita T, Masuda J, Hoshino K, Seko T, Tanigawa T, Kitamura T, Ichikawa T, Ito M, Dohi K (2020) Prevalence and prognosis of familial hypercholesterolemia in patients with acute coronary syndrome in Mie prefecture, Japan—report from Mie ACS registry. Circ J 85:9–18 - PubMed
11. Matsuo H, Dohi K, Machida H, Takeuchi H, Aoki T, Nishimura H, Yasutomi M, Senga M, Ichikawa T, Kakuta K, Mizutani Y, Tanoue A, Isaka N, Oosugi K, Koyabu S, Sakurai M, Fukui Y, Kakimoto H, Sugimoto T, Ohnishi T, Murata T, Ishikawa E, Okamoto R, Yamada T, Ogura T, Nishimura Y, Tanigawa T, Nomura S, Nishikawa M, Ito M (2018) Echocardiographic assessment of cardiac structural and functional abnormalities in patients with end-stage renal disease receiving chronic hemodialysis. Circ J 82:586–595 - PubMed
12. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, Van Es GA, Zuckerman B, Fearon WF, Taggart D, Kappetein AP, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW (2018) Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation 137:2635–2650 - PubMed
13. Iseki K, Fukiyama K (2000) Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis 36:820–825 - PubMed
14. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD (2010) Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary. Circulation 121:357–365 - PubMed
15. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799–805 - PubMed
16. Shroff GR, Frederick PD, Herzog CA (2012) Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes o. Am Heart J 163:399–406 - PubMed
17. Akashi N, Sakakura K, Watanabe Y, Noguchi M, Taniguchi Y, Yamamoto K, Wada H, Momomura S, Fujita H (2018) The comparison of clinical outcomes in patients with acute myocardial infarction and advanced chronic kidney disease on chronic hemodialysis versus off hemodialysis. Heart Vessel 33:713–721 - PubMed
18. Killip T, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 20:457–464 - PubMed
19. Granger CB (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:2345–2353 - PubMed
20. Fox KAA, Goodman SG, Klein W, Brieger D, Steg G, Dabbous O, Avezum Á (2002) Management of acute coronary syndromes. Variations in practice and outcome: findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 23:1177–1189 - PubMed
21. Fujii T, Suzuki T, Torii S, Murakami T, Nakano M, Nakazawa G, Masuda N, Shinozaki N, Matsukage T, Ogata N, Yoshimachi F, Ikari Y (2014) Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients. Circ J 78:2950–2954 - PubMed
22. Komiyama K, Nakamura M, Tanabe K, Niikura H, Fujimoto H, Oikawa K, Daida H, Yamamoto T, Nagao K, Takayama M (2018) In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: Applicability of the GRACE risk score. J Cardiol 71:251–258 - PubMed
23. Gurm HS, Gore JM, Anderson FA, Wyman A, Fox KAA, Steg PG, Eagle KA, Registry G, Events C (2012) Investigators G. Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] registry ). Am J Cardiol 109:19–25 - PubMed
24. Hioki H, Motoki H, Izawa A, Kashima Y, Miura T, Ebisawa S, Tomita T, Miyashita Y, Koyama J, Ikeda U (2016) Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction. Heart Vessel 31:687–693 - PubMed

Publication Types

• Journal Article